Compound class:
Synthetic organic
Comment: The chemical structure for elunonavir was obtained from WHO Proposed list 125. The IUPAC>SMILES conversion maps to PubChem CID 135301900. Via SureChEMBL we can trace this compound to a Gilead Sciences patent that claims antiviral compounds for the treatment of HIV [1]. From the patent it would appear that elunonavir is an HIV protease inhibitor.
|
|
References |
1. Bacon EM, Chin E, Cottell JJ, Katana AA, Kato D, Link JO, Shapiro N, Martin TAT, Yang Z-Y. (2020)
HIV inhibitor compounds. Patent number: US10752636B2. Assignee: Gilead Sciences Inc. Priority date: 06/02/2017. Publication date: 25/08/2020. |